Similarly, Abediankenari et al. (2011) found that MICB gene expression was higher in the peripheral blood mononuclear cells collected from 32.6% of patients with progressive MS compared to controls (p = 0.002). The gene discussed is MICB; the disease is myeloid sarcoma.